The histrionic rate of advancement in biotech­nology has brought about a widespread revolution in the health care system. The discov­eries in molecular biology, genomics, cellular and tissue engineering, new drug discovery and delivery techniques, and bio-imaging hold the promise of improving health care by en­hancing the diagnostic capabilities and substantially expanding therapeutic options.

Hence, there is emergence of therapies that have a lot less side effects, vaccines which are safer than ever before and innovative diagnos­tic aids that are faster and smaller in size with warranted accuracy. Over the past decade, the pace of biotechnological research has markedly accelerated, while the scope and expenditures for the biotechnology research enterprises have increased substantially.

IT automation, sometimes referred to as infrastructure automation, is the use of software to create repeatable instructions and processes to replace or reduce human interaction with IT systems. Automation software works within the confines of those instructions, tools, and frameworks to carry out the tasks with little to no human intervention.

Automation is key to IT optimization and digital transformation. Modern, dynamic IT environments need to be able to scale faster than ever and IT automation is vital to making that happen.

Nanotechnology is a field of research and innovation concerned with building 'things' - generally, materials and devices - on the scale of atoms and molecules. A nanometre is one-billionth of a metre: ten times the diameter of a hydrogen atom. The diameter of a human hair is, on average, 80,000 nanometres. At such scales, the ordinary rules of physics and chemistry no longer apply. For instance, materials' characteristics, such as their colour, strength, conductivity and reactivity, can differ substantially between the nanoscale and the macro. Carbon 'nanotubes' are 100 times stronger than steel but six times lighter.